| Literature DB >> 31871459 |
Laila Chaoui1,2, RajaaAit Mhand2, Fouad Mellouki2, Naima Rhallabi2.
Abstract
Nosocomial infections (NIs) are known worldwide and remain a major problem despite scientific and technical advances in the field of health. The severity of the infection depends on the characteristics of the microorganisms involved and the high frequency of resistant pathogens in the hospital environment. The aim of this study is to determine the distribution of pathogenic bacteria (and their resistance to antibiotics) that spread on hospital surfaces, more specifically, on those of various departments in the Provincial Hospital Center (PHC) of Mohammedia, Morocco. A cross-sectional study was conducted from March 2017 to April 2018. Samples were collected by swabbing the hospital surfaces, and the isolated bacteria were checked for their susceptibility to antibiotics by the Kirby-Bauer disk diffusion method following the standards of the Clinical and Laboratory Standards Institute (CLSI). Among 200 swab samples, 176 (88%) showed bacterial growth. Gram-negative isolates were predominant at 51.5% (101/196), while the Gram-positives were at 48.5% (95/196). The main isolates are Enterobacteria weighted at 31.6% (62/196), Staphylococcus aureus reaching 24% (47/196), Pseudomonas aeruginosa at 9.2% (18/196), and Acinetobacter spp. with 3.3% (6/196). Moreover, the antimicrobial susceptibility profile of the isolates showed that about 31.7% (32/101) of the Gram-negative isolates were found to be MDR. This resistance is also high among isolates of S. aureus of which 44.7% (20/47) were methicillin-resistant Staphylococcus aureus (MRSA). Contamination of hospital surfaces by MDR bacteria is a real danger to public health. The concept of environmental bacterial reservoir is a reality that requires strict compliance with current guidelines and recommendations for hand hygiene, cleaning, and disinfection of surfaces in hospitals.Entities:
Year: 2019 PMID: 31871459 PMCID: PMC6906863 DOI: 10.1155/2019/3236526
Source DB: PubMed Journal: Int J Microbiol
Total number of screened equipment and surfaces and organisms detected.
| Gram | Sampling site | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Organism detected | Floor and wall (50) | Patient beds (46) | Bedside table (15) | Door/window handle (35) | Sinks and taps (10) | Hospital equipment (24) | Other items (20) | Total = 200 | |
| Gram + Total = 95 (48.5%) |
| 12 | 7 | — | 4 | 2 | 3 | 4 | 32 (16.3%) |
|
| 8 | 3 | — | 2 | — | — | 2 | 15 (7.7%) | |
|
| 12 | 11 | 4 | 10 | — | 6 | 4 | 47 (24%) | |
|
| — | 01 | — | — | — | — | — | 01 (0.5%) | |
|
| 2 | 7 | 1 | 4 | 1 | 3 | 1 | 19 (18.8%) | |
|
| 3 | 1 | 2 | 4 | 4 | 4 | 18 (9.2%) | ||
|
| 3 | 6 | — | 2 | 2 | 2 | 3 | 18 (8.1%) | |
|
| 2 | 2 | 2 | 4 | — | — | — | 10 (5.1% | |
|
| 4 | — | 2 | 0 | — | 1 | 1 | 8 (4.1%) | |
|
| 2 | — | 0 | 3 | — | — | 2 | 7 (3.6%) | |
|
| 3 | — | — | — | 1 | — | 2 | 6 (3.1%) | |
|
| 4 | — | — | 2 | — | — | — | 6 (3.1%) | |
|
| 1 | — | — | — | 1 | 3 | — | 5 (2.6%) | |
|
| — | 1 | 1 | — | — | — | — | 2 (1%) | |
|
| — | — | — | — | 2 | — | — | 2 (1%) | |
| Total = 196 |
|
|
|
|
|
|
|
| |
Other items: objects that are not used directly to the patient such as scialytics, trolleys, and some closet; —, no detection of specified organism in this particular object; mixed growth of bacteria.
Antibiotic susceptibility pattern of GNB and Staphylococcus aureus.
| Antibiotics |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| |
| Penicillin | — | — | — | — | — | — | — | — | 25 (53.2%) |
| Ampicillin | 19 (100%) | 18 (100%) | 10 (10%) | 5 (63%) | 4 (80%) | 1 (50%) | — | — | — |
| Amoxicillin-clavulanic acid | 18 (95%) | 15 (83.3%) | 10 (100%) | 3 (38%) | 5 (100%) | 1 (50%) | — | — | — |
| Piperacillin | 7 (36.8%) | 10 (55.6%) | 10 (100%) | 00 | 3 (60%) | 1 (50%) | 8 (44.4%) | 5 (83%) | — |
| Piperacillin + tazobactam | 4 (21%) | 1 (5.6%) | 2 (20%) | 00 | 1 (20%) | 00 | 4 (22.2%) | 3 (50%) | — |
| Ticarcillin | 11 (57.9%) | 13 (72.2%) | 9 (90%) | 00 | 3 (60%) | 00 | 8 (44.4%) | 5 (83%) | — |
| Ceftriaxone | 11 (57.9%) | 5 (27.8%) | 2 (20%) | 4 (50%) | 1 (20%) | 00 | — | 4 (67%) | — |
| Ceftazidime | 8 (42.1%) | 6 (33.3%) | 2 (20%) | 0 (13%) | 1 (20%) | 1 (50%) | 8 (44.4%) | 4 (67%) | — |
| Cefepime | 00 | 00 | 00 | 00 | 00 | 00 | 00 | 00 | — |
| Cefoxitin | 8 (42.1%) | 6 (33.3%) | 8 (80%) | 00 | 1 (20%) | 2 (100%) | — | — | 21 (44.7%) |
| Erythromycin | — | — | — | — | — | — | — | — | 26 (55.3%) |
| Imipenem | 00 (00%) | 00 (0%) | 00 (0%) | 00 | 00 | 00 | 1 (5.6%) | 3 (50%) | — |
| Chloramphenicol | 6 (31.6%) | 10 (55.6%) | 00 (0%) | 5 (63%) | 2 (40%) | 00 | — | — | 21 (44.7%) |
| Gentamicin | 10 (52.6%) | 1 (5.6%) | 8 (80%) | 2 (25%) | 1 (20%) | 00 | 8 (44.4%) | 2 (33.3%) | 19 (40.4%) |
| Kanamycin | — | — | — | — | — | — | — | — | 27 (57.4%) |
| Tetracycline | 14 (73.7%) | 7 (38.9%) | 7 (70%) | 2 (25%) | 1 (20%) | 1 (50%) | — | 5 (83%) | 25 (53.2%) |
| Ciprofloxacin | 5 (26.3%) | 6 (33.3%) | 5 (50%) | 7 (88%) | 3 (60%) | 00 | 10 (55.6%) | 2 (33.3%) | 29 (61.7%) |
| Levofloxacin | 4 (21%) | 4 (22.2%) | 2 (20%) | 1 (13%) | 1 (20%) | 00 | 8 (44.4%) | 5 (83%) | 6 (12.8%) |
| Fusidic acid | — | — | — | — | — | — | — | — | 16 (34.04%) |
| Trimethoprim-sulfamethoxazol | 9 (47.37%) | 8 (44.4%) | 2 (20%) | 3 (38%) | 2 (40%) | 2 (100%) | — | — | 19 (40.4%) |
| ESBL | 8 (42.11%) | 9 (50%) | 2 (20%) | 00 | 00 | 1 (50%) | — | — | — |
—: not applicable; ESBL: extended-spectrum beta-lactamase.